Searched for
USV PHARMA
Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- Rs 12,000 crore magic pill race begins to shrink India's pot bellies. Which pharma stocks will win GLP-1 war?India's GLP-1 market is set for a massive boom. Following patent expiry, generic versions of semaglutide are launching at significantly low...
- USV Pharma buys 79% stake in Wellbeing Nutrition for Rs 1,583 croreUSV Pharma has acquired a 79% stake in Wellbeing Nutrition for Rs 1,583 crore in an all-cash deal, expanding into India’s nutraceutical sup...
- AI jitters continue to hit IT; USV Pharma buys Wellbeing stakeIT stocks slid sharply Thursday on rising fears of AI-led disruption. Here’s more in today’s ETtech Top 5:
- HUL turns ₹70 cr bet in Wellbeing Nutrition into ₹307 cr exitHindustan Unilever has divested its 19.8% stake in Wellbeing Nutrition to UVS Pharma for Rs 307 crore. This move comes after HUL's initial ...
- USV Pharma leads race to buy 85% stake in Wellbeing Nutrition at Rs 1,600 crore valuationThe Mumbai-based brand, owned by Nutritionlab, counts Hindustan Unilever and Fireside Ventures among its early backers. HUL and Fireside — ...
- Pharma companies bet on flagship products to grow in strengthIndian drug manufacturers are utilizing flagship products or "mother brands" to introduce new combinations and establish leadership in ther...
- USV in talks with Novartis to buy Jalra Trademark for Rs. 200 CroreMumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal...
- I-T probes pharmaceutical company's nexus with doctorsThe department, in the past few days, carried out raids at 20 premises of USV India and three reputed doctors in Mumbai, and one each in Na...
- Anti-diabetic drug cartel issue reaches CCI, Health MinistryCCI had been informed about the cartelisation allegations in a letter dated Feb 27, ET reported earlier. At that time, Novartis had denied ...
- Code for pharma firms to have more teethThe voluntary code, initially applicable till June 2015, has been given four extensions despite the department repeatedly admitting it wasn...
- Pharma cos offer freebies to doctors, violate code: MPThe CAG, in a report in 2015, criticised the Central Board of Direct Taxes for allowing promotional expenses by pharma companies as deducti...
- Diabetes drug ban to help companies like USV, Sun Pharma, LupinIn the wake of a government ban on top-selling diabetes drug, pioglitazone , the volumes are expected to shift to other classes such as fir...
- Pharma MNCs eye Indian companies to collaborate on drugs, moleculesTo take advantage of the robust growth of the domestic pharma industry, MNCs are looking at alliances and partnerships.
- Novartis ties up with USV to market Galvus in IndiaNovartis has tied up with leading healthcare company - USV - to market its anti-diabetic product Galvus.
- Now, USV looks for generic gains in a tough US marketIn spite of challenging market conditions, more and more Indian pharma companies are entering the US generic drugs market.
- USV's Daman facility gets FDA approvalUSV Limited says its solid formulations facility at Daman has received US FDA approval.
- USV in talks to take over Canadian co for $50 mnMumbai-based pharma major USV is now close to making an acquisition in Canada.
Load More
